To verify this, western blot analysis was performed, and the results showed that BAY-885 treatment led to an increase in the expression of p-PERK, ATF4, and CHOP in a dose-dependent manner in BC cells (Figure 3e). The gene discussed is EIF2AK3; the disease is breast cancer.